LIVE GENETICALLY ATTENUATED MALARIA VACCINE - Patent SG149058(A1)
Filed:
Dec 20, 2004
Published:
Jan 29, 2009
Abstract
LIVE GENETICALLY ATTENUATED MALARIA VACCINE Method for inoculating a vertebrate host against malaria, by administering to the host a live Plasmodium organism that is genetically engineered to disrupt a liver-stage-specific gene function.Applicants
-
SEATTLE BIOMEDICAL RES INST
Inventors
-
MUELLER ANN-KRISTIN
-
KAPPE STEFAN H I
-
MATUSCHEWKI KAI-UWE C
Application Number
200809507-7Priority Claims
US63122804Family Members
AU2004309380(A1) -
Live genetically attenuated malaria vaccine
WO2005063991(A2) -
VACCIN CONTRE LA MALARIA ATTENUE GENETIQUEMENT ET VIVANT
CA2551193(A1) -
VACCIN CONTRE LA MALARIA ATTENUE GENETIQUEMENT ET VIVANT
WO2005063991(A3) -
LIVE GENETICALLY ATTENUATED MALARIA VACCINE
US2005226896(A1) -
Live genetically attenuated malaria vaccine
EP1706418(A2) -
GENETISCH ABGESCHWÄCHTER MALARIA-LEBENDIMPFSTOFF
US7122179(B2) -
Live genetically attenuated malaria vaccine
KR20060123346(A) -
LIVE GENETICALLY ATTENUATED MALARIA VACCINE
US2007009556(A1) -
Live genetically attenuated malaria vaccine
BRPI0417762(A) -
organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US7261884(B2) -
Live genetically attenuated malaria vaccine
US2008032388(A1) -
Live Genetically Attenuated Malaria Vaccine
SG149058(A1) -
LIVE GENETICALLY ATTENUATED MALARIA VACCINE
